| Literature DB >> 27540966 |
Jannik E Jakobsen1, Marianne G Johansen1, Mette Schmidt2, Ying Liu3, Rong Li3, Henrik Callesen3, Margarita Melnikova4, Mette Habekost1, Carmela Matrone1, Yvonne Bouter5, Thomas A Bayer5, Anders Lade Nielsen1, Monika Duthie6, Paul E Fraser6, Ida E Holm7,4, Arne Lund Jørgensen1.
Abstract
Mutations in the amyloid-β protein precursor gene (AβPP), the presenilin 1 gene (PSEN1) or the presenilin 2 gene (PSEN2) that increase production of the AβPP-derived peptide Aβ42 cause early-onset Alzheimer's disease. Rodent models of the disease show that further increase in Aβ42 production and earlier brain pathology can be obtained by coexpressing AβPP and PSEN1 mutations. To generate such elevated Aβ42 level in a large animal model, we produced Göttingen minipigs carrying in their genome one copy of a human PSEN1 cDNA with the Met146Ile (PSEN1M146I) mutation and three copies of a human AβPP695 cDNA with the Lys670Asn/Met671Leu (AβPPsw) double-mutation. Both transgenes were expressed in fibroblasts and in the brain, and their respective proteins were processed normally. Immunohistochemical staining with Aβ42-specific antibodies detected intraneuronal accumulation of Aβ42 in brains from a 10- and an 18-month-old pig. Such accumulation may represent an early event in the pathogenesis of Alzheimer's disease.Entities:
Keywords: Alzheimer’s disease; amyloid; porcine model; presenilin; transgenic
Mesh:
Substances:
Year: 2016 PMID: 27540966 DOI: 10.3233/JAD-160408
Source DB: PubMed Journal: J Alzheimers Dis ISSN: 1387-2877 Impact factor: 4.472